What is the vaccine Vakderm for dogs against? - briefly
The Vakderm vaccine for dogs is specifically designed to protect against distemper and adenovirus type-2 (hepatitis), which are highly contagious and potentially fatal viral diseases in canines.
What is the vaccine Vakderm for dogs against? - in detail
The vaccine Vakderm for dogs, also known as Canine Distemper-Adenovirus-Parvovirus (DAPP) vaccine, is designed to protect canines from several highly contagious and potentially fatal viral diseases. These include:
-
Canine Distemper Virus (CDV): This virus affects the respiratory and nervous systems of dogs, causing symptoms such as fever, coughing, diarrhea, vomiting, seizures, and paralysis. It is highly contagious and often fatal if left untreated.
-
Canine Adenovirus Type 1 (CAV-1): Also known as Infectious Canine Hepatitis, this virus primarily affects the liver and can cause severe damage to other organs as well. Symptoms include fever, lethargy, loss of appetite, vomiting, diarrhea, and abdominal pain.
-
Canine Adenovirus Type 2 (CAV-2): This virus is responsible for infectious tracheobronchitis, commonly known as kennel cough. It causes inflammation of the respiratory tract, resulting in symptoms such as a persistent cough, runny nose, and sometimes fever.
-
Canine Parvovirus (CPV): This highly contagious virus attacks the gastrointestinal system, causing severe vomiting, diarrhea, weight loss, and dehydration. It is particularly dangerous in puppies and unvaccinated dogs, with a high mortality rate if left untreated.
The Vakderm vaccine is administered to puppies starting at 6-8 weeks of age, with boosters given every 2-4 weeks until the pup reaches 16 weeks old. After the initial series, annual boosters are recommended to maintain optimal protection against these serious diseases. It is essential for dog owners to consult their veterinarian regarding the vaccination schedule and any specific needs based on the dog's age, health status, and lifestyle.